ABSTRACT -Subchronic toxicity of a horseradish extract (HRE), consisting mainly of a mixture of allyl isothiocyanate (AITC) and other isothiocyanates, was investigated with administration at concentrations of 0, 0.0125, 0.025 and 0.05% of HRE in drinking water for 13 weeks to male and female F344 rats. For comparison, treatment with 0.0425% of AITC was similarly performed. Body weight gain was reduced in the 0.05% HRE and AITC males as compared to the 0% controls, and the cause was considered at least partly related to decreased water consumption due to the acrid smell of the test substance and decreased food consumption. Serum biochemistry demonstrated increased urea nitrogen in 0.025 and 0.05% HRE and AITC males and 0.0125-0.05% HRE and AITC females, along with decreased total cholesterol in 0.0125-0.05% HRE females. On histopathological assessment, papillary/nodular hyperplasia of bladder mucosa was observed in 0.05% HRE and AITC males and females, in addition to simple mucosal hyperplasia found in all treated groups. Based on the above findings, no-observed-adverse-effect levels (NOAELs) were estimated to be below 0.0125% of HRE for both males and females, corresponding to 9.4 and 8.0 mg/kg body weight/day, respectively, and there appeared to be comparable toxicological properties of HRE to AITC, such as the inductive effect of significant proliferative lesions in the urinary bladder.
INTRODUCTION
Horseradish extract (HRE) is distilled with steam from milled horseradish (Armoracia Rusticana) roots, and its principal component is allyl isothiocyanate (AITC). HRE also includes other isothiocyanates (ITCs), such as phenethyl isothiocyanate (PEITC), butenyl isothiocyanate and pentenyl isothiocyanate (Tokarska and Karwowska, 1983) . Like AITC and other ITCs, it is used throughout the world as a food additive for its expected antioxidative, antimicrobial and/or flavoring effects. HRE itself is also approved as a food additive and widely used for the above-mentioned purposes in Japan (Uematsu et al., 2002) . ITCs are present in many Brassica vegetables, and an estimated daily intake of ITC precursors, glucosinolates, from Brassica vegetables was 75 mg, and it is likely that certain individuals will consume more than 300 mg total glucosinolates per day in the UK (Sones et al., 1984) . However, the daily intake of ITCs from food additives is uncertain.
ITCs including PEITC and benzyl isothiocyanate (BITC) have been shown to possess chemopreventive properties against chemically induced carcinogenesis in animal models (Morse et al., 1991; Nishikawa et al., 1996; Wattenberg, 1977) . These potent effects have been considered partly due to the direct inhibition and/ or down-regulation of the cytochrome P-450 enzymes involved in carcinogen metabolic activation (Goosen et al., 2001; Nakajima et al., 2001; Nishikawa et al., 1997) and the induction of the phase II detoxification enzymes Toxic effects of a horseradish extract and allyl isothiocyanate in the urinary bladder after 13-week administration in drinking water to F344 rats (Bogaards et al., 1990; Dingley et al., 2003; Munday and Munday, 2004) . In vitro molecular studies also have suggested chemopreventive effects of ITCs, including AITC (Xu et al., 2006) , due to mechanisms other than alteration of carcinogen metabolism, e.g., through induction of cellular apoptosis.
On the other hand, carcinogenic potential of AITC has also been indicated. Gavage administration in conventional 2-year bioassays in rats and mice resulted in urinary bladder tumor induction limited to the rat (NTP, 1982) . PEITC and BITC also showed promoting activity and/or complete carcinogenic potential in the urinary bladder or liver of rats Ogawa et al., 1998) . This carcinogenic and/or tumor promoting activity of ITCs in the urinary bladder is considered at least partly to be derived from cell proliferation stimuli following mucosal damage by free forms of ITCs cleaved from the conjugated metabolites in urine (Masutomi et al., 2001) . With regard to genotoxicity, AITC induced DNA-damage/gene mutations in E. coli and Salmonella, and PEITC induced micronucleus, chromosomal aberration or sister chromatid exchange in HepG2 and Chinese hamster ovary cell lines (Kassie and Knasmuller, 2000; Musk et al., 1995) . These results indicate that carcinogenic effect of ITCs in the urinary bladder epithelium may partly reflect their genotoxic potential.
General toxicological profiles of ITCs except for AITC have yet to be examined in detail. A pre-chronic toxicity study of AITC was conducted with 4-weeks gavage administration at doses up to 50 and 400 mg/kg body weight/day to mice and rats, respectively, and stomach mucosa and/or urinary bladder wall thickening were detected, but no obvious gross or microscopic changes were found in another 13-week study at doses up to 25 mg/kg body weight/day (NTP, 1982) . In a 6-week gavage study of AITC in rats, several toxicological findings, such as decreased body and thymus weights, increased liver weight and dilatation of distal tubules in the kidneys, were reported at 20 and/or 40 mg/kg body weight/day (Lewerenz et al., 1988) . A subchronic toxicity study of PEITC in male rats with 13-weeks dietary administration at concentrations up to 0.1% also revealed degenerative lesions in the liver (Morse et al., 1989) . As for pharmacokinetics of ITCs, PEITC has been studied extensively to characterize its properties. PEITC has high oral bioavailability and shows non linear elimination due at least partly to saturation of metabolism at doses 0.3-65 mg/kg body weight in rats (Telang et al., 2009) . ITCs are consumed from foodstuff or food additives in man, and the absorption is suspected to be slower than that of gavage cases. Therefore, in vivo toxicity studies with administration in diet or drinking water are possibly preferable to gavage studies. In the present experiment, subchronic toxicity of HRE, consisting mainly of a mixture of AITC and other ITCs, was evaluated with 13-week administration in drinking water to F344 rats. The objective of the present study is to estimate no-observed-adverse-effect levels (NOAELs) of HRE and to compare the toxicological properties of HRE to those of AITC, which shows urinary bladder toxicities in rats.
MATERIALS AND METHODS

2-Week preliminary study
A total of 35 male F344/DuCrj rats at 6 weeks old of age (Charles River Japan; Kanagawa, Japan) were divided into 7 groups, including HRE at concentrations of 0 (control, 0.03% Tween 80), 0.025, 0.05 and 0.1% and AITC at 0.025, 0.05 and 0.1% in drinking water each. Body weights and food consumptions were measured weekly, and water consumption was assessed twice a week. At the end of the experiment, all animals were euthanized by exsanguination under ether anesthesia, and histopathological examination was performed on the liver, kidneys, stomach and urinary bladder.
Chemicals
HRE and AITC were obtained from Yamachu Wasabi (Saitama, Japan). The HRE was distilled with steam from horseradish roots, and the AITC was synthesized. The HRE sample was a clear yellow and acrid liquid and demonstrated contents of AITC, PEITC, butenyl isothiocyanate and pentenyl isothiocyanate of 82-86, 9, 3 and 1%, respectively (internal data of Yamachu Wasabi). AITC was a clear, colorless and acrid liquid, and the purity was over 97%. AITC dissolves sparingly in water but is soluble in ethanol and miscible with most organic solvents (Tanimura, 1999) . For administration in drinking water, HRE and AITC were individually mixed with Tween 80 (Wako Pure Chemical, Osaka, Japan) at an amount so that the final concentration became 0.03%, and then diluted with reverse osmosis (deionized) water. The mixed water was prepared just before the treatment twice a week throughout the experiment. The stability of HRE was evaluated by measurement of AITC concentrations in the drinking water and confirmed as being 76, 62 and 40% after still standing for 1, 2 and 4 days, respectively, at room temperature. The stability of AITC was also 40-44% after 4 days in the same conditions. No major peaks of the break down products were found on the high-performance liquid chromatography charts in the both HRE and AITC cases (Fig. 1) .
Experimental animals and housing conditions
A total of 50 male and 50 female F344/DuCrj rats at 5 weeks old of age were purchased from Charles River Japan and acclimated for 1 week prior to the commencement of the experiment. Rats were allocated with body weight-basis randomization to fi ve groups per sex, each consisting of 10 males and 10 females, and maintained in a room with a barrier system under the following conditions: temperature of 24 ± 1°C; relative humidity 55 ± 5 %; ventilation frequency of 18 times/hr; and a 12-hr light/dark cycle. The animals were housed fi ve rats per plastic cage with sterilized soft wood chips (Sankyo Laboratory Service, Tokyo, Japan) and allowed free access to drinking water containing HRE or AITC and a basal diet CRF-1 (Oriental Yeast, Tokyo, Japan) ad libitum. The test substance-supplemented drinking water in clear polycarbonate bottles was replaced twice a week throughout the experiment.
Experimental design
The animals of both sexes received HRE at concentrations of 0 (control, 0.03% Tween 80), 0.0125, 0.025 and 0.05% and AITC at 0.0425% in drinking water for 13 weeks, based on a 2-week preliminary study in male rats. In the preliminary study, signifi cantly lowered body weights and water consumption in the 0.1% HRE and AITC groups, obviously reduced water consumption but no signifi cant body weight changes in the 0.025 and 0.05% HRE and AITC groups and simple and papillary/nodular mucosal hyperplasia of the urinary bladder in the 0.025-0.1% HRE and AITC groups were observed (Table 1) . Clinical signs and mortality were checked daily. Body weights and food consumptions were measured weekly, and water consumption was assessed at the time of drinking water replacement. At the end of the experiment, all animals were fasted overnight and euthanized by exsanguination under ether anesthesia after blood sample collection from the abdominal aorta for hematology and blood biochemistry. The blood sampling of each group males were performed in rotation at 10:00-14:30 and those of females were at 14:30-16:30 in a day. The experiments were carried out in accordance with the Guide for Animal Experimentation in the National Institute of Health Sciences of Japan.
Hematological examinations were performed using an automatic hematology analyzer, M-2000 (Toa Medical Electronics; Hyogo, Japan) and the following parameters were determined: red blood cell count (RBC), hemoglobin concentration (Hb), hematocrit (Ht), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), Fig. 1 . HPLC charts demonstrating a main peak of AITC on day 0 (A), day 1 (B), and a main peak and several small peaks on day 2 (C) after preparation of the 0.01% HRE-mixed water. The small peaks were not identical with presumed AITC-decomposed materials, allylcyanid, allyl disulfi de and allyl trisulfi de.
platelet count (Plt) and white blood cell count (WBC). Differential leukocyte counts and the reticulocyte count (Ebl) were obtained with a Microx HEG-120A (Omron Tateishi Electronics; Tokyo, Japan). Serum biochemistry was conducted for the following 18 parameters: total protein (TP), albumin (Alb), albumin/globulin ratio (A/G), glucose, total bilirubin (T-Bil), total cholesterol (T-Cho), triglyceride (TG), γ-glutamyl transpeptidase (γ-GTP), aspartate transaminase (AsT), alanine transaminase (AlT), alkaline phosphatase (ALP), blood urea nitrogen (BUN), creatinine (Cre), calcium (Ca), inorganic phosphorus (IP), sodium (Na), potassium (K) and chloride (Cl).
All animals were subjected to a complete necropsy. Brain, thymus, lungs, heart, spleen, liver, kidneys, adrenals and testes were weighed. In addition to these organs, nasal cavity, trachea, aorta, pituitary, thyroids, parathyroids, salivary glands, tongue, esophagus, stomach, duodenum, jejunum, ileum, cecum, colon, rectum, pancreas, urinary bladder, epididymides, prostate, seminal vesicles, ovaries, uterus, vagina, mammary gland, skin, mesenteric and submandibular lymph nodes, sternum, femur including bone marrow, sciatic nerve, trigeminal nerve, spinal cord (cervical, thoracic and lumber cords), eyes, and thigh muscle were excised. All these organs and tissues were fixed in 10% buffered formalin except for testes fixed in Bouin's solution. Paraffin-embedded tissue sections of all organs/tissues were routinely prepared and stained with hematoxilin and eosin. Histopathological examination was performed on all organs and tissues in the control, HRE 0.05% and AITC group animals of both sexes. In addition, urinary bladder and stomach specimens of the HRE 0.0125 and 0.025% groups were also assessed.
The present study design was basically in accordance with Guidelines for Designation of Food Additives and for Revision of Standards for Use of Food Additives of Japan (1996) . The experiments were carried out in accordance with the Guide for Animal Experimentation of the National Institute of Health Sciences of Japan.
Statistics
Variance in data for body weights, hematology, serum biochemistry and organ weights was checked for homogeneity by Bartlett's procedure. When the data were homogeneous, one-way analysis of variance (ANOVA) was applied. In the heterogeneous cases, the Kruskal-Wallis test was used. When statistically significant differences were indicated, Dunnett's multiple test was employed for comparison between control and treated groups. For incidences of histopathological findings, the Fisher's exact probability test was applied. Significance was inferred at the 5, 1, and 0.1% levels.
RESULTS
In-life parameters
No mortality or obvious clinical signs were found in any animals throughout the experimental period. No effects on body weight were observed in females, whereas HRE 0.05% group males from week 1 and AITC group males from week 2 showed lower body weights as compared to Liver (g/100 g body weight) 3.9 ± 0.2 a 4.1 ± 0.1 4.1 ± 0.1 3.9 ± 0.2 4.0 ± 0.1 4.1 ± 0.1 3.9 ± 0.2 Kidneys (g/100 g body weight)
0.7 ± 0.0 a 0.7 ± 0.0 0.7 ± 0.0 0.9 ± 0.0 ** 0.8 ± 0.0 0.8 ± 0.0 1.0 ± 0. the controls until the end of the experiment (Fig. 2 ). Food and water consumption was decreased with a dose-related manner in all HRE treated groups of both males and females, and also with AITC treatment (Table 2) . Average intakes of HRE in the 0.0125, 0.025 and 0.05% groups were 12.7, 19.4 and 36.4 mg/kg body weight/day in males and 10.8, 20.5 and 36.5 mg/kg body weight/day in females, respectively. Average intakes of AITC in AITC group males and females were 40.0 and 37.9 mg/kg body weight/day, respectively. Estimated AITC intakes of HRE 0.05% group were 30.6 and 30.7 mg/kg body weight/day in males and females, respectively, appearing to be lower than those in AITC group.
Hematology/serum biochemistry
Although Ebl was increased in AITC group males, no obvious change with a dose-relation was noted in HRP group males (Table 3 ). In females, Mono was decreased in HRE 0.05% and AITC groups (Table 4) . These changes were considered not to be toxicologically signifi cant, since there was no change in other hematological parameters or histopathology of related organs/tissues. Slight increase in MCV found in HRE 0.0125 and 0.05% group females without a dose-relation was not considered test substance related (Table 4) .
In males, BUN was increased in the HRE 0.025 and 0.05% and AITC groups, whereas Cre was decreased in the AITC group (Table 5) . Slight increase in Alb with HRE 0.025 and 0.05% and slight increase in A/G for HRE 0.05% was detected, but the toxicological significance was not clear, since TP levels were not changed. Cl was slightly increased at HRE 0.05%, but without change in other electrolyte parameters (Table 5 ). In females, a decrease of T-Cho and an increase of BUN were observed in HRE-treated groups in a dose-related manner, and BUN was also increased in the AITC group (Table 6) .
Organ weights
In males, increase in relative kidney weight was noted in the HRE 0.025 and 0.05% groups. The following alterations were considered to be related to the body weight changes: decrease in absolute weights of brain, lungs, heart, spleen, liver, kidneys and testes in the HRE 0.05% group; increase in relative brain weight in the HRE 0.05% and AITC groups; and increase in relative testes weights in the HRE 0.05% group (Table 7) . In females, increase in absolute and/or relative kidney weights was observed in the HRE 0.025, 0.05% and AITC groups. Slight increase in relative spleen weights found with HRE 0.025 and 0.05% (Table 8) was considered not to be toxicologically significant, since there were no related-histopathological changes.
Histopathology HRE-or AITC-related lesions were found in the urinary bladder and stomach (Table 9 ). In the urinary bladder, simple mucosal hyperplasia was observed in all HRE 78.2 ± 4.9 Mono 2.3 ± 0.8 2.1 ± 0.7 1.7 ± 1.0 1.2 ± 0.8 * 1.2 ± 0.5 ** Values are means ± S.Ds. *,**: Significantly different from the control value at p < 0.05 and p < 0.01, respectively. Vol. 36 No. 6 or AITC treated groups of both sexes, with statistical signifi cance noted for HRE 0.025% females and HRE 0.05% and AITC males and females. In addition, papillary/nodular hyperplasia was observed in HRE 0.05% and AITC groups of both sexes (Fig. 3) . In the stomach, diffuse mucosal hyperplasia in pylorus was found in both sexes receiving AITC. Other fi ndings in stomach of HRE 0.05% or AITC groups were not considered to be related to the treatment, because similar changes were found in other dose groups including the controls without dose-dependence or they are solitary cases. In other organs, several lesions were found in control, HRE 0.05% or AITC groups, but they are known to occur spontaneously in this strain, and neither increases in their incidences nor specific types of lesions were observed in the HRE 0.05% and AITC groups (Table 10 ). Therefore, they were not considered test substance related.
DISCUSSION
In the present study of general toxicity of HRE administered in the drinking water at concentrations of 0, 0.0125, 0.025 and 0.05% to F344 rats for 13 weeks, as well as 0.0425% of AITC for comparison, test substancerelated changes were observed with regard to body weights, water and food consumption, serum BUN and 2.33 ± 0.08 2.37 ± 0.11 2.37 ± 0.10 2.41 ± 0.10 2.40 ± 0.10 Kidneys (g%) 0.59 ± 0.02 0.60 ± 0.02 0.62 ± 0.03 * 0.63 ± 0.03 ** 0.61 ± 0.02 Adrenals (mg%) 11.8 ± 1.3 12.7 ± 1.1 13.0 ± 2.4 13.6 ± 2.3 13.4 ± 2.5 Testes (g%)
1.02 ± 0.03 1.01 ± 0.09 1.02 ± 0.07 1.09 ± 0.03 ** 1.06 ± 0.04 Values are means ± S.Ds. *,**: Significantly different from the control value at p < 0.05 and p < 0.01, respectively. Vol. 36 No. 6 2.14 ± 0.10 2.12 ± 0.14 2.16 ± 0.04 2.23 ± 0.14 2.15 ± 0.08 Kidneys (g%) 0.61 ± 0.02 0.62 ± 0.05 0.65 ± 0.03 * 0.68 ± 0.03 ** 0.66 ± 0.03 * Adrenals (mg%) 21.7 ± 1.9 21.9 ± 4.2 24.4 ± 2.1 23.5 ± 3.1 24.5 ± 3.0 Values are means ± S.Ds. *,**: Significantly different from the control value at p < 0.05 and p < 0.01, respectively. a : The number of the samples measured was nine, due to an error in data recording. T-Cho levels, kidney weights and histopathology of the urinary bladder.
Food and water consumption were decreased in a dose-related manner in all HRE treated groups of both sexes and also in AITC treated males and females. The decreased water consumption was considered to be due to the acrid smell of HRE and AITC. The cause of decreased food consumption might relate the decreased water consumption, but the possibility remains that HRE and AITC directly affect the function of digestive organs or physiological metabolism resulting in decreased food appetite. Decreased body weight gain observed in HRE 0.05% and AITC group males was more than 10% relative to the control, and it was considered at least partly to be related to the decreased food and water consumption. From another viewpoint, the decreased body weight gain was limited to the HRE 0.05% and AITC group males despite the marked decrease in water consumption with a dose-relation in all HRE treated groups of both sexes, partly demonstrating a physiological adaptation in HRE 0.025 and 0.0125% groups. The decreased water consumption in the AITC group was comparable to those in the HRE 0.025 and 0.0125% group males and females, respectively, suggesting the repellent effect of HRE might be stronger than that of AITC.
In serum biochemistry, BUN was increased in males of HRE 0.025 and 0.05% groups and females of 0.0125-0.05% groups and AITC group of both sexes. In addition, absolute and/or relative kidney weights were increased in HRE 0.025 and 0.05% groups of both sexes and AITC group females. There is a possibility that dehydration secondary to the obviously decreased water consumption caused the BUN elevation. However, no significant changes were found in other parameters indicating dehydration, such as increased RBC, Ht and TP levels. These results indicate that HRE and AITC might possess renal toxicological potentials in rats or physiological adaptation to the decreased water consumption might partly be related to the organ weight and BUN changes, but no microscopic changes were found in the kidneys of any of the HRE-or AITC-treated animals. On the other hand, AITC was previously reported to induce renal microscopic changes such as dilatation of distal tubules and increased desquamation in rats given a dose of 20 mg/kg body weight/day by gavage for 6 weeks (Lewerenz et al., 1988) . T-Cho was also found to be decreased with a dose-dependence in females given HRE, whereas among ITCs, BITC was reported to increase serum cholesterol levels (Lewerenz et al., 1992) . Although the composition of the test substance and the procedure for administration were different, the cause of these discrepancies may be due to some other factors.
Regarding urinary bladder toxicity, simple mucosal hyperplasia was microscopically observed in all HRE or AITC treated groups of both sexes, together with papillary/nodular hyperplasia in the HRE 0.05% and AITC groups. The incidence and degree of the proliferative lesions observed in AITC groups were comparable to those in HRE 0.05% group of both sexes, and there appeared no more significant urinary bladder toxicological properties with HRE than with AITC. Urine is reported to be the major route of excretion of AITC (Bollard et al., 1997) , and free forms of ITCs cleaved from the conjugated metabolites in urine were shown to induce mucosal damage in urinary bladder of rats (Masutomi et al., 2001) . Therefore, the distribution profile of ITCs including AITC could be strongly related to the urinary bladder toxicity in rats.
In a NTP report, AITC administration by 4-weeks gavage at doses up to 50 and 400 mg/kg body weight/day to mice and rats, respectively, was documented to induce mucosal thickening of gastric and/or urinary bladder (NTP, 1982) . Carcinogenic potential of AITC was previously examined by gavage administration in a conventional 2-year bioassay in rats and mice, and urinary bladder papillomas were induced in male rats at 12 and 25 mg/ kg body weight/day (NTP, 1982) . Because HRE administration caused urothelial proliferative lesions, i.e. simple mucosal hyperplasia and papillary/nodular hyperplasia in the present study at comparable doses to the previous AITC cases, HRE might also be expected to possess carcinogenic effects in the rat urinary bladder. As compared to the results of our 2-week preliminary study in male rats administered 0.025-0.1% HRE and AITC each (Table 1) , however, the incidence of papillary/nodular hyperplasia was obviously lower in the 0.05% HRE and AITC group males of the present 13-week study (p < 0.05). Akagi et al. (2003) earlier demonstrated that dietary administration of other ITCs, such as PEITC and BITC, induced marked inflammatory changes along with mucosal damages in the urinary bladder of rats, with peaks apparent on days 2 or 3, and these changes were considered to be directly correlated with subsequent tumor promotion/formation. However, Sugiura et al. (2003) reported simple and papillary/nodular hyperplasia induced by PEITC in the urinary bladder of rats to be reversible. Both in the present 2-week preliminary and 13-week studies, no obvious inflammatory changes/mucosal damage were observed, and it was not clear whether such toxicological changes in early stages related induction of proliferative lesions in the urinary bladder of rats treated with HRE/AITC. Therefore, further studies are needed to clarify whether HRE/AITC induces mucosal inflammatory damages in the shorter term and HRE actually shows tumor promotional and/or carcinogenic effects in the rat urinary bladder in the longer term.
In conclusions, NOAELs were estimated to be below 0.0125% of HRE for both males and females, corresponding to 12.7 and 10.8 mg/kg body weight/day, respectively, and HRE appeared to possess comparable toxicological properties to AITC, such as the inductive effect of significant proliferative lesions in the urinary bladder. Considering the stability data of the HRE-mixed drinking water, the NOAELs were revised to 9.4 and 8.0 mg/kg body weight/day for males and females, respectively.
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